BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19934718)

  • 1. Antipsychotic prescribing practices following withdrawal of concomitant carbamazepine.
    Strack DK; Leckband SG; Meyer JM
    J Psychiatr Pract; 2009 Nov; 15(6):442-8. PubMed ID: 19934718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics.
    Grimm SW; Richtand NM; Winter HR; Stams KR; Reele SB
    Br J Clin Pharmacol; 2006 Jan; 61(1):58-69. PubMed ID: 16390352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of psychotic disorders with aripiprazole in the emergency psychiatric setting.
    Raja M; Azzoni A
    Psychiatr Danub; 2008 Sep; 20(3):323-8. PubMed ID: 18827757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiologic interaction carbamazepine with atypical neuroleptics. Acute mixed carbamazepine and quetiapine intoxication--case report].
    Hydzik P; Balicka-Slusarczyk B; Jastrzebski M
    Przegl Lek; 2011; 68(8):499-502. PubMed ID: 22010449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Explicit review of risperidone long-acting injection prescribing practice.
    Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
    J Clin Pharm Ther; 2011 Dec; 36(6):651-63. PubMed ID: 22023342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole in a patient susceptible to urinary side effects of antipsychotics.
    Sahoo S
    Isr J Psychiatry Relat Sci; 2007; 44(1):74-5. PubMed ID: 17668467
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of aripiprazole and concomitant carbamazepine.
    Citrome L; Macher JP; Salazar DE; Mallikaarjun S; Boulton DW
    J Clin Psychopharmacol; 2007 Jun; 27(3):279-83. PubMed ID: 17502775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically significant adverse events from a drug interaction between quetiapine and atazanavir-ritonavir in two patients.
    Pollack TM; McCoy C; Stead W
    Pharmacotherapy; 2009 Nov; 29(11):1386-91. PubMed ID: 19857154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
    Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
    J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone.
    Letmaier M; Painold A; Holl AK; Grohmann R; Vergin H
    Int J Psychiatry Clin Pract; 2012 Jun; 16(2):153-6. PubMed ID: 22211772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone long-acting therapy prescribing patterns and their impact on early discontinuation of treatment in a large Medicaid population.
    Boaz TL; Constantine RJ; Robst J; Becker MA; Howe AM
    J Clin Psychiatry; 2011 Aug; 72(8):1079-85. PubMed ID: 21034690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy.
    Gianfrancesco F; Wang RH; Nasrallah HA
    Ann Clin Psychiatry; 2006; 18(1):9-17. PubMed ID: 16517448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant antipsychotic prescribing in US outpatient settings.
    Aparasu RR; Jano E; Bhatara V
    Res Social Adm Pharm; 2009 Sep; 5(3):234-41. PubMed ID: 19733824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
    McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
    J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactorrhea - side effect of risperidone in combination with depakine chrono in a patient with bipolar disorder.
    Peitl MV; Peitl V; Grahovac T; Pavlović E
    Psychiatr Danub; 2010 Mar; 22(1):125-7. PubMed ID: 20305608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.